COPD Trial, Recruiting NCT05976919 Sponsor: University of Leeds Condition: COPD
Back to Copd

COPD Trial, Recruiting

NCT05976919
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have previously been diagnosed with an airways disease, according to European Respiratory Society guidelines.
  • People who have never smoked, or who used to smoke but no longer do.
  • People aged between 18 and 65 years old, male or female.
  • People who are able to give written consent to participate.
  • People who can fully understand spoken and written English.
  • People with Cystic Fibrosis who are currently taking a triple CFTR modulator treatment (a specific type of Cystic Fibrosis medication).
  • People with Cystic Fibrosis who are not taking any CFTR modulator medication.
  • Healthy volunteers who have no symptoms, have never used an inhaler, and have no history of respiratory (breathing) disease.

Who may not be able to join:

  • People who have had a serious flare-up of their condition requiring a hospital stay or a course of steroid tablets in the past two months.
  • People for whom exercise testing involving the heart and lungs would not be considered safe (confirm with trial site).
  • People for whom standard breathing function tests would not be considered safe (confirm with trial site).
  • People for whom a DEXA scan (a type of low-level X-ray used to measure body composition) would not be suitable — for example, due to pregnancy, recent use of contrast dye in medical imaging, or body weight considerations.
  • People who are unable to walk independently, or who have a physical condition affecting movement or the ability to complete exercise testing.
  • People with significant difficulties in thinking or understanding that would prevent them from safely completing the study tests or providing written consent.
  • People who are currently using oxygen therapy.
  • People who are unable to give consent to participate.
  • People who have an active infection with Burkholderia Cepacia Complex, tuberculosis, or Mycobacterium abscessus (specific types of bacterial infections relevant to Cystic Fibrosis).
  • People who have had a lung transplant.
  • People who have been diagnosed with a heart or cardiovascular (circulation) condition.
  • People whose blood test results are outside the normal range — for example, showing anaemia or moderate to severe kidney problems.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 01133437639

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of Leeds
Registry
ClinicalTrials.gov
Start date
1 October 2023
Est. completion
31 July 2025

Where this trial is recruiting

🇬🇧 United Kingdom

Primary endpoints

Physical activity

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov